PMID: 18435678
Question: Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
Correct Answer: no

======================= Launch the MCC process =======================
PMID: 18435678
Question: Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
The question seeks to determine whether Kell alloimmunization during pregnancy is associated with fetal thrombocytopenia, which refers to abnormally low platelet counts in the fetus.

**2. Evidence Evaluation**
The abstract presents data from a retrospective cohort study involving 42 pregnancies with severe Kell alloimmunization. Fetal thrombocytopenia (platelet count <150 x 10⁹/L) was observed in 10% of these cases, but none had clinically significant thrombocytopenia (platelet count <50 x 10⁹/L). In contrast, a higher incidence of thrombocytopenia was noted in RhD alloimmunized pregnancies, especially among fetuses with severe hydrops.

**3. Conclusion**
The evidence suggests that while there is a presence of some level of thrombocytopenia in Kell alloimmunized pregnancies, it does not reach clinically significant levels. Therefore, Kell alloimmunization is generally not associated with substantial fetal thrombocytopenia.

**4. Final Answer**
**My final choice is: "no"**
GPT selected: no

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether Kell alloimmunization in pregnancy is associated with fetal thrombocytopenia (low platelet count). Key information to identify in the abstract includes the incidence of thrombocytopenia in Kell-alloimmunized pregnancies compared to controls (RhD alloimmunization), definitions of thrombocytopenia, and outcomes, especially clinically significant cases (platelet count <50 x 10⁹/L).  

**2. Evidence Evaluation**  
- The study found fetal thrombocytopenia (platelet count <150 x 10⁹/L) in 10% (4/42) of Kell cases vs. 26% (84/318) in RhD controls.  
- **Clinically significant thrombocytopenia (platelet count <50 x 10⁹/L)** was **not observed in any Kell-alloimmunized fetus**, even among those with severe hydrops (15 cases). In contrast, 23% of severely hydropic RhD cases had this severe thrombocytopenia.  
- The abstract explicitly states that Kell-alloimmunized fetuses are "generally not at risk for substantial thrombocytopenia" compared to RhD cases.  

The data show a clear distinction between Kell and RhD groups, with Kell-associated thrombocytopenia being rare and never reaching clinically significant levels. The study’s conclusion directly addresses the question.  

**3. Conclusion**  
The evidence indicates that while mild thrombocytopenia (non-clinically significant) occurred in a small fraction of Kell cases, severe thrombocytopenia (the clinically relevant outcome) was absent. Since the question focuses on association with thrombocytopenia in general, the answer depends on whether "associated" refers to any thrombocytopenia or clinically significant cases. However, the abstract emphasizes that Kell is **not** associated with **substantial** thrombocytopenia. Given the context of clinical significance in the study, the answer is "no."  

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether Kell alloimmunization in pregnancy is associated with fetal thrombocytopenia. Key information to evaluate includes the incidence and severity of thrombocytopenia in fetuses affected by Kell alloimmunization compared to controls (RhD alloimmunization).

**2. Evidence Evaluation**  
- **Data from the Abstract**:  
  - **Kell Group**: 4/42 (10%) fetuses had thrombocytopenia (platelet count <150 x 10⁹/L), with none (including severe hydrops cases) having clinically significant thrombocytopenia (<50 x 10⁹/L).  
  - **RhD Group**: 84/318 (26%) fetuses had thrombocytopenia, with 7/30 (23%) severely hydropic RhD fetuses having clinically significant thrombocytopenia.  
- **Conclusion Statement**: The abstract explicitly states that Kell alloimmunized fetuses with severe anemia are "generally not at risk for substantial thrombocytopenia," contrasting with RhD cases.  

**3. Conclusion**  
The study demonstrates a significantly lower incidence of thrombocytopenia in Kell alloimmunized fetuses compared to RhD alloimmunized fetuses, with no severe thrombocytopenia observed in the Kell group. This evidence strongly supports the conclusion that Kell alloimmunization is **not** associated with clinically significant fetal thrombocytopenia.  

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

Initial consensus: All models selected no